« Back
Home /
Vandetanib-d4

Vandetanib-d4

Manufacturer	Toronto Research Chemicals
Category	Oncology Reagents & Chemicals Other Chemicals By Organ Lung Cancer Bladder Cancer
Type	Biochemicals
Specific against	other
Amount	2.5mg
Item no.	TRC-V097102-2,5mg
eClass 6.1	32160405
eClass 9.0	32160490
Available
CAS Number	1215100-18-7
Mol. Formula	C22H20D4BrFN4O2
Mol. Weight	479, 38
Subcategory	Aromatics, Heterocycles, Inhibitors, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals,
Appearance	No Data Available
Application Notes	A labelled Vandetanib; a once-daily oral inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor kinase activity. The activity of vandetanib plus docetaxel was assessed in patients with previously treated non-small-cell lung cancer (NSCLC).
Melting Pt.	No Data Available
Boiling Pt.	No Data Available
Solubility	No Data Available
Stability	No Data Available
Storage Condition	No Data Available

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 2.5mg

available

Delivery expected until 8/2/2024